You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
RITAMIX(01936.HK)就制造及供应NMN膳食补充剂订合作协议
阿思达克 12-09 09:26
RITAMIX(01936.HK)公布,公司与马来西亚上市的科鼎控股之全资附属,就科鼎向中国及东南亚(包括马来西亚)市场制造及供应NMN膳食补充剂订立合作协议。科鼎及集团亦将与马来西亚理工大学合作,以进行基於NMN的保健品的研究。

集团指,NMN为一种前体,或者说为制造烟醯胺腺嘌呤二核(甘)酸(NAD+)的成分,而NAD+为一种於人类细胞内发现的重要辅(酉每),用於进行葡萄糖代谢等细胞过程。研究发现,NAD+的水平会随着生物体老化而下降,从而令许多生物功能减慢。食用NMN膳食补充剂(主要以胶囊或粉末形式销售)的主要原因为提高人体NAD+的水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account